FXYD2 and central nervous system cancer: Univariate Cox analysis was used to identify the factors affecting the survival of glioma patients, including sex, age, recurrence, histopathology (HE), WHO grade, IDH mutation status, 1p/19q co-deletion status, methylation status of MGMT, extent of resection, radiotherapy or chemotherapy status, and FXYD2 mRNA expression.